SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
WST reported Third-Quarter 2026 results. The stock moved +3.2% on the print.
WSTearnings

Earnings reactions, page 9

West Pharmaceutical Services, Inc. (WST) FY2026 earnings

October 29, 2026 · SharpeIQ Research Desk

Reported results

  • Net sales were $874.5 million, an increase of 8.7% compared to the prior-year period.
  • Diluted EPS (U.S. GAAP) was $3.02, an increase of 57.3% compared to the prior-year period.
  • Adjusted-diluted EPS (non-U.S. GAAP) was $2.66, an increase of 35.7% compared to the prior-year period.
  • Proprietary Products segment net sales were $728.8 million, an increase of 12.6% compared to the prior-year period.
  • West Vantage segment net sales were $145.7 million, a decrease of 7.3% compared to the prior-year period.
  • Reported operating profit margin (U.S. GAAP) was 30.6% for the third quarter of 2026.

Guidance

  • Full-year 2026 net sales guidance is a range of $3.41 billion to $3.42 billion.
  • Full-year 2026 adjusted-diluted EPS guidance is a range of $9.38 to $9.48.
  • Full-year 2026 organic net sales growth guidance is a range of 11.3% to 11.6%.
  • Full-year 2026 capital spending guidance is a range of $215 million to $220 million.

Notes

The company recorded a pre-tax gain of $55.7 million on the sale of its SmartDose® 3.5mL On-Body Delivery System assets in the third quarter of 2026.

Price and volatility reaction

The stock moved +3.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -19.2 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release403.642026-10-28
Close after release416.672026-10-29
Realised move+3.2%close to close
30d ATM IV change-19.2 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →